Liver Fibrosis Data is on the horizon suggesting that GLP-1s play a role in reversing liver fibrosis
Figure 1 4.1.1 Cardiovascular outcomes in SGLT2 inhibitors: safety studies The EMPA-REG OUTCOME trial, which included 7020 patients with T2DM, was the first to demonstrate the cardiovascular protective effects of empagliflozin (54, 56)
2008 Feb 11;180(3):645
Para continuar, ingresa atu cuenta trace-id: 868b533c-da02-4552-87a7-589fc8c097f3 Usamos cookies para mejorar tu experiencia en Mercado Libre
Choose Healthy Fats Certain fats, especially monounsaturated and omega-3 fatty acids, can promote GLP-1 secretion
Compared with exenatide, lixisenatide is generally well tolerated, with a lower incidence of hypoglycemia, lower immune response at the injection site, and less side effects such as nausea and vomiting